标题：Research Grade Anti-RSV F/Fusion glycoprotein F0 (ADI-14359)，AntibodySystem Laboratories
货号：DVV02811
产品链接：http://www.antibodysystem.com/product/9005.html
寄主物种：Human
形式：Liquid
存储缓冲区：0.01M PBS, pH 7.4.
浓度：1 mg/ml
纯度：>95% by SDS-PAGE.
克隆性：Monoclonal
应用：Research Grade Biosimilar
储存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
免费热线：027-65279366 /18108604356
QQ：2663991332
咨询邮箱：products@biolabreagent.com
选购商城：https://www.antibodysystem.com
微信公众平台：佰乐博生物Biolab Reagents
参考文献：
Dissociation of the respiratory syncytial virus F protein-specific human IgG, IgA and IgM response. PMID: 33574352
Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. PMID: 10930660
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection. PMID: 29029312
Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage. PMID: 1375280
Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses. PMID: 3012869
Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic. PMID: 11277694
Alkaline phosphatase fusions to the respiratory syncytial virus F protein as an approach to analyze its membrane topology. PMID: 2558867
Clinical Potential of Prefusion RSV F-specific Antibodies. PMID: 29054341
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. PMID: 26333350
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. PMID: 24179220
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models. PMID: 34973849
Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study. PMID: 33087438
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity. PMID: 35455333
Two RSV Platforms for G, F, or G+F Proteins VLPs. PMID: 32824936
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years. PMID: 32320465
RSV pre-fusion F protein enhances the G protein antibody and anti-infectious responses. PMID: 36535957
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults. PMID: 32851411
Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection. PMID: 32849580
A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine. PMID: 36542692
Transient opening of trimeric prefusion RSV F proteins. PMID: 31068578
A novel RSV F-Fc fusion protein vaccine reduces lung injury induced by respiratory syncytial virus infection. PMID: 30822450
Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV. PMID: 33669275
A live single-cycle RSV vaccine expressing prefusion F protein. PMID: 36306605
Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model. PMID: 34702618
Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. PMID: 29057917
Immunogenicity of RSV F DNA Vaccine in BALB/c Mice. PMID: 27688769
Adenovectors encoding RSV-F protein induce durable and mucosal immunity in macaques after two intramuscular administrations. PMID: 31885877
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs. PMID: 26319066
Alternative conformations of a major antigenic site on RSV F. PMID: 31306469
Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice. PMID: 32566260
The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV. PMID: 28604155
A Parainfluenza Virus Vector Expressing the Respiratory Syncytial Virus (RSV) Prefusion F Protein Is More Effective than RSV for Boosting a Primary Immunization with RSV. PMID: 33115876
New therapies for acute RSV infections: where are we? PMID: 30610420
The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate. PMID: 36602367
A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge. PMID: 28298602
Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates. PMID: 34696372
A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models. PMID: 25793508
Neutralizing epitopes of RSV and palivizumab resistance in Japan. PMID: 28867684
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant. PMID: 27583777
The respiratory syncytial virus (RSV) prefusion F-protein functional antibody repertoire in adult healthy donors. PMID: 33998144
An Optimized FI-RSV Vaccine Effectively Protects Cotton Rats and BALB/c Mice without Causing Enhanced Respiratory Disease. PMID: 36298640
Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F. PMID: 28835504
Improved epitope resolution of the prefusion trimer-specific antibody AM14 bound to the RSV F glycoprotein. PMID: 34420474
In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor. PMID: 28952549
Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection. PMID: 34118428
Characterisation of RSV Fusion Proteins from South African Patients with RSV Disease, 2019 to 2020. PMID: 36366419
A human antibody potently neutralizes RSV by targeting the conserved hydrophobic region of prefusion F. PMID: 36853487
Novel antigens for RSV vaccines. PMID: 26070108
Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein. PMID: 27258388
Enhanced immunogenicity of a respiratory syncytial virus (RSV) F subunit vaccine formulated with the adjuvant GLA-SE in cynomolgus macaques. PMID: 26206269
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. PMID: 21586636
Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus. PMID: 27682426
The RSV F and G glycoproteins interact to form a complex on the surface of infected cells. PMID: 18036342
Enhancing Anti-G Antibody Induction by a Live Single-Cycle Prefusion F-Expressing RSV Vaccine Improves In Vitro and In Vivo Efficacy. PMID: 36366572
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models. PMID: 36992257
Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses. PMID: 19622401
Protection of calves by a prefusion-stabilized bovine RSV F vaccine. PMID: 29021918
Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein. PMID: 30769923
Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor. PMID: 31951396
RSV entry inhibitors block F-protein mediated fusion with model membranes. PMID: 12076763
Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. PMID: 1995956
A DNA Vaccine in Which the RSV-F Ectodomain Is Covalently Linked to the Burkholderia pseudomallei Antigens TssM and Hcp1 Augments the Humoral and Cytotoxic Response in Mice. PMID: 31681300
Detailed Evolutionary Analyses of the F Gene in the Respiratory Syncytial Virus Subgroup A. PMID: 34960794
Respiratory syncytial virus entry inhibitors targeting the F protein. PMID: 23325327
Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells. PMID: 23623857
Antibody Epitopes of Pneumovirus Fusion Proteins. PMID: 31849961
Strategic priorities for respiratory syncytial virus (RSV) vaccine development. PMID: 23598484
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. PMID: 2251875
Comparison of Palivizumab-Like Antibody Binding to Different Conformations of the RSV F Protein in RSV-Infected Adult Hematopoietic Cell Transplant Recipients. PMID: 29365155
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. PMID: 23951084
Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine: Structure, antigenic profile, immunogenicity, and protection. PMID: 31416644
